Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

12.41

-1.55 (-11.10%)

At close: Mar 27, 2026, 4:00 PM EDT

12.41

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:34 PM EDT

Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	276.98	178.96	170.28	185.31	154.34
Revenue Growth (YoY)	54.77%	5.10%	-8.11%	20.06%	56.88%
Cost of Revenue	71.36	72.08	75.55	57.91	49.3
Gross Profit	205.62	106.88	94.72	127.4	105.04
Selling, General & Admin	167.27	157.57	172.51	184.13	169.97
Depreciation & Amortization Expenses	1.7	1.7	1.7	1.7	1.7
Research & Development	93.77	102.95	122.12	141.76	142.34
Other Operating Expenses	-	7.21	25.43	-	-
Total Operating Expenses	262.74	269.43	321.76	327.59	314.01
Operating Income	-57.12	-162.55	-227.04	-200.19	-208.97
Interest Expense	-11.78	-11.58	-13.8	-4.24	-
Other Non-Operating Income (Expense)	9.44	14.53	15.53	4.06	1.67
Total Non-Operating Income (Expense)	-2.33	2.95	1.73	-0.18	1.67
Pretax Income	-59.46	-159.6	-225.3	-200.37	-207.3
Net Income	-59.5	-159.49	-225.25	-200.19	-207.28
Minority Interest in Earnings	0.04	-0.1	-0.05	-0.18	-0.02
Net Income to Common	-59.5	-159.49	-225.25	-200.19	-207.28
Shares Outstanding (Basic)	152	147	144	143	140
Shares Outstanding (Diluted)	152	147	144	143	140
Shares Change (YoY)	3.14%	1.88%	1.31%	1.54%	6.96%
EPS (Basic)	-0.39	-1.08	-1.56	-1.40	-1.48
EPS (Diluted)	-0.39	-1.08	-1.56	-1.40	-1.48
Free Cash Flow	-48.95	-98.88	-167.02	-200.29	-254.47
Free Cash Flow Per Share	-0.32	-0.67	-1.16	-1.41	-1.81
Gross Margin	74.24%	59.72%	55.63%	68.75%	68.06%
Operating Margin	-20.62%	-90.83%	-133.33%	-108.03%	-135.39%
Profit Margin	-21.47%	-89.18%	-132.32%	-108.13%	-134.31%
FCF Margin	-17.67%	-55.25%	-98.09%	-108.09%	-164.87%
EBITDA	-39.29	-143.29	-204.8	-179.27	-195.01
EBITDA Margin	-14.19%	-80.07%	-120.28%	-96.74%	-126.35%
EBIT	-57.12	-162.55	-227.04	-200.19	-208.97
EBIT Margin	-20.62%	-90.83%	-133.33%	-108.03%	-135.39%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q